SGLT‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory ma...
SGLT‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model
About this item
Full title
Author / Creator
Publisher
Oxford: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Polycystic ovary syndrome (PCOS) is a common endocrine, reproductive, and metabolic disorder affecting females. The management of PCOS is challenging and current interventions are not enough to deal with all consequences of this syndrome. We explored the beneficial effect of combined sodium glucose co transporter‐2 inhibitor (SGLT‐2i); (empaglifloz...
Alternative Titles
Full title
SGLT‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1a232c3ae26a4ab98f6df331ce0382ba
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1a232c3ae26a4ab98f6df331ce0382ba
Other Identifiers
E-ISSN
2051-817X
DOI
10.14814/phy2.15858
